Time trade-off procedure for measuring health utilities loss with human papillomavirus-induced diseases: a multicenter, retrospective, observational pilot study in Italy

Rosa Pasqualina De Vincenzo, Maria Gabriella Ferrandina, Giovanni Scambia, Marco Petrillo, Fs Mennini, D Panatto, A Marcellusi, P Cristoforoni, E Di Capua, T Sasso, Carlo Antonio Ricci, N Trivellizzi, A Capone, R. Gasparini

Risultato della ricerca: Contributo in rivistaArticolo in rivista

11 Citazioni (Scopus)

Abstract

The economic evaluation of any human papillomavirus (HPV) vaccination strategy requires the measurement of clinical benefits (quality-adjusted life-years [QALY]) gained to reflect both the increase in life expectancy and the economic benefits associated with an effective intervention.
Lingua originaleEnglish
pagine (da-a)1084-1084-1095.e4
RivistaClinical Therapeutics
Volume33
DOI
Stato di pubblicazionePubblicato - 2011

Keywords

  • Adult
  • Algorithms
  • Cervical Intraepithelial Neoplasia
  • Condylomata Acuminata
  • Cross-Sectional Studies
  • Feasibility Studies
  • Female
  • Health Status
  • Humans
  • Italy
  • Middle Aged
  • Papillomavirus Infections
  • Pilot Projects
  • Quality of Life
  • Quality-Adjusted Life Years
  • Questionnaires
  • Retrospective Studies
  • Time Factors
  • Uterine Cervical Neoplasms
  • Young Adult

Fingerprint Entra nei temi di ricerca di 'Time trade-off procedure for measuring health utilities loss with human papillomavirus-induced diseases: a multicenter, retrospective, observational pilot study in Italy'. Insieme formano una fingerprint unica.

Cita questo